Estimated reading time: 3 minutes
Medtronic, a leading medical technology company, recently announced FDA approval for a groundbreaking pain treatment: a spinal-cord implant. The device is called Inceptiv, and it is aimed at alleviating chronic pain. This approval marks a significant milestone in the company's efforts to expand its presence in pain management. They are particularly interested in it as an alternative to opioid medications.
Opioids continue to be a problem in the world of pain management. In the last few decades, drug overdoses due to opioids have skyrocketed. The epidemic began in the 90s with prescription opioids, with the CDC identifying two additional "waves." 2010 saw a surge due to heroin, and 2013 because of synthetic opioids like fentanyl.
What is the Device?
Inceptiv works by delivering electrical pulses to the spinal cord. This effectively interrupts pain signals before they reach the brain. Unlike previous versions, this new device can dynamically adjust the intensity of stimulation based on signals from nerve fibers. With that level of personalization and response, it can enhance patient comfort.
Inceptiv has a few advanced features. It boasts a rechargeable lithium battery, ultra-thin design, and precise stimulation adjustment capabilities. These features contribute to its distinction as the world's smallest fully implantable spinal-cord stimulator.
Spinal-Cord Stimulators
Doctors implant these devices directly into the spinal cord. They send low levels of electricity directly along the spinal cord to relieve pain. They typically consist of two parts: thin wires and a small battery pack. Surgeons place the wires, also called electrodes, between the spinal cord and the vertebrae. The battery pack is put under the skin, usually near the buttocks or abdomen.
Patients using traditional spinal-cord stimulators have reported discomfort and limited effectiveness. Infections can cause swelling and pain, or more general symptoms like a fever. This often leads to the device being removed. In contrast, Inceptiv's adaptive technology aims to mimic the body's natural responses. The hope is this will give the patient a more seamless and comfortable experience.
A Need for New Treatments
The approval of Inceptiv comes at a time with heightened awareness of the risks associated with opioid medications. There is an increased need for alternative pain management solutions. While spinal-cord stimulators offer promising benefits, experts emphasize the complexity of pain management and the importance of comprehensive care.
While some experts express optimism about the potential benefits of advanced spinal-cord stimulators like Inceptiv, others caution that pain management requires individualized care. Technological interventions alone may not resolve the problem.
Medtronic's FDA approval for Inceptiv represents a significant advancement in pain management technology! The hope is it is a more sophisticated and adaptive solution for chronic pain. With this, the company aims to address the evolving needs of patients and healthcare providers amidst growing concerns about opioid use and addiction.
Over 300,000 members have joined PatientsLikeMe to manage their chronic pain. We have resources, health tracking tools, and community challenges to help with condition management. Creating an account is free! Join today.